Cargando…

88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric

BACKGROUND: Over diagnosis of hospital-onset Clostridioides difficile infection (HO-CDI) is directly tied to inappropriate C. difficile testing which does not distinguish between infected or colonized individuals. This can lead to inappropriate therapy. Multiple studies have utilized Computerized Cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Cory, Aragon, Deborah, Knepper, Bryan C, Jenkins, Timothy C, Shihadeh, Katherine C, Young, Heather
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777055/
http://dx.doi.org/10.1093/ofid/ofaa439.398
_version_ 1783630816946946048
author Hussain, Cory
Aragon, Deborah
Knepper, Bryan C
Jenkins, Timothy C
Shihadeh, Katherine C
Young, Heather
author_facet Hussain, Cory
Aragon, Deborah
Knepper, Bryan C
Jenkins, Timothy C
Shihadeh, Katherine C
Young, Heather
author_sort Hussain, Cory
collection PubMed
description BACKGROUND: Over diagnosis of hospital-onset Clostridioides difficile infection (HO-CDI) is directly tied to inappropriate C. difficile testing which does not distinguish between infected or colonized individuals. This can lead to inappropriate therapy. Multiple studies have utilized Computerized Clinical Decision Support (CCDS) tools to reduce inappropriate C. difficile testing. Our study looks at the impact of a Self-Assessment CCDS tools on C. difficile testing for HO-CDI and oral vancomycin utilization as a balancing metric. METHODS: Our institution utilizes a two-step test to diagnose HO-CDI that consists of toxin A/B enzyme immunoassay followed by a confirmatory PCR. We applied a self-assessment driven CCDS approach to reduce testing for HO-CDI. Our intervention was deployed in the 3(rd) quarter of 2018. It asked 3 questions about stool frequency, laxative use and previous C. difficile testing in the order itself. Inappropriate indications for testing included any of the following: < 3 bowel movements within 24 hours, receipt of a laxative within the past 48 hours, or a previous C. difficile test within the previous 7 days. Ordering providers would self-answer these questions. A ‘yes’ response to any of the three questions prevented further test ordering; though respondents had the freedom to change the answer and still proceed with the test order. We evaluated 3 metrics that were all calculated per 1000 inpatient census days: oral vancomycin usage, HO-CDI rates and C. difficile testing rates. RESULTS: Compared to baseline, our intervention resulted in a significant reduction of C. difficile testing and HO-CDI rates (Figure 1, Table 1). Oral vancomycin usage also decreased significantly (Figure 2, Table 1). Figure 1. C. difficile testing and Hospital Onset C. difficile Infection Rates by Month, Before and After Intervention [Image: see text] Figure 2. Oral Vancomycin Utilization by Month, Before and After Intervention [Image: see text] Table 1. Changes in Median Rates of C. difficile testing, Hospital Onset C. difficile Infections and Vancomycin Utilization, Before and After Intervention. [Image: see text] CONCLUSION: Our self-assessment driven CCDS-based diagnostic stewardship resulted in a significant reduction in inappropriate C. difficile testing for HO-CDI and HO-CDI rates. Oral vancomycin utilization as a balancing metric also decreased significantly. This was despite the use of a self-assessment driven approach with the freedom to change the answers in order to proceed with the test order. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777055
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77770552021-01-07 88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric Hussain, Cory Aragon, Deborah Knepper, Bryan C Jenkins, Timothy C Shihadeh, Katherine C Young, Heather Open Forum Infect Dis Poster Abstracts BACKGROUND: Over diagnosis of hospital-onset Clostridioides difficile infection (HO-CDI) is directly tied to inappropriate C. difficile testing which does not distinguish between infected or colonized individuals. This can lead to inappropriate therapy. Multiple studies have utilized Computerized Clinical Decision Support (CCDS) tools to reduce inappropriate C. difficile testing. Our study looks at the impact of a Self-Assessment CCDS tools on C. difficile testing for HO-CDI and oral vancomycin utilization as a balancing metric. METHODS: Our institution utilizes a two-step test to diagnose HO-CDI that consists of toxin A/B enzyme immunoassay followed by a confirmatory PCR. We applied a self-assessment driven CCDS approach to reduce testing for HO-CDI. Our intervention was deployed in the 3(rd) quarter of 2018. It asked 3 questions about stool frequency, laxative use and previous C. difficile testing in the order itself. Inappropriate indications for testing included any of the following: < 3 bowel movements within 24 hours, receipt of a laxative within the past 48 hours, or a previous C. difficile test within the previous 7 days. Ordering providers would self-answer these questions. A ‘yes’ response to any of the three questions prevented further test ordering; though respondents had the freedom to change the answer and still proceed with the test order. We evaluated 3 metrics that were all calculated per 1000 inpatient census days: oral vancomycin usage, HO-CDI rates and C. difficile testing rates. RESULTS: Compared to baseline, our intervention resulted in a significant reduction of C. difficile testing and HO-CDI rates (Figure 1, Table 1). Oral vancomycin usage also decreased significantly (Figure 2, Table 1). Figure 1. C. difficile testing and Hospital Onset C. difficile Infection Rates by Month, Before and After Intervention [Image: see text] Figure 2. Oral Vancomycin Utilization by Month, Before and After Intervention [Image: see text] Table 1. Changes in Median Rates of C. difficile testing, Hospital Onset C. difficile Infections and Vancomycin Utilization, Before and After Intervention. [Image: see text] CONCLUSION: Our self-assessment driven CCDS-based diagnostic stewardship resulted in a significant reduction in inappropriate C. difficile testing for HO-CDI and HO-CDI rates. Oral vancomycin utilization as a balancing metric also decreased significantly. This was despite the use of a self-assessment driven approach with the freedom to change the answers in order to proceed with the test order. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777055/ http://dx.doi.org/10.1093/ofid/ofaa439.398 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Hussain, Cory
Aragon, Deborah
Knepper, Bryan C
Jenkins, Timothy C
Shihadeh, Katherine C
Young, Heather
88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric
title 88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric
title_full 88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric
title_fullStr 88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric
title_full_unstemmed 88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric
title_short 88. Impact of a Computerized Clinical Decision Support Tool on clostridioides Difficile Testing and Oral Vancomycin Utilization as a Balancing Metric
title_sort 88. impact of a computerized clinical decision support tool on clostridioides difficile testing and oral vancomycin utilization as a balancing metric
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777055/
http://dx.doi.org/10.1093/ofid/ofaa439.398
work_keys_str_mv AT hussaincory 88impactofacomputerizedclinicaldecisionsupporttoolonclostridioidesdifficiletestingandoralvancomycinutilizationasabalancingmetric
AT aragondeborah 88impactofacomputerizedclinicaldecisionsupporttoolonclostridioidesdifficiletestingandoralvancomycinutilizationasabalancingmetric
AT knepperbryanc 88impactofacomputerizedclinicaldecisionsupporttoolonclostridioidesdifficiletestingandoralvancomycinutilizationasabalancingmetric
AT jenkinstimothyc 88impactofacomputerizedclinicaldecisionsupporttoolonclostridioidesdifficiletestingandoralvancomycinutilizationasabalancingmetric
AT shihadehkatherinec 88impactofacomputerizedclinicaldecisionsupporttoolonclostridioidesdifficiletestingandoralvancomycinutilizationasabalancingmetric
AT youngheather 88impactofacomputerizedclinicaldecisionsupporttoolonclostridioidesdifficiletestingandoralvancomycinutilizationasabalancingmetric